van Haren F M P, Sleigh J W, Pickkers P, Van der Hoeven J G
Intensive Care Department, Waikato Hospital, Hamilton, New Zealand.
Anaesth Intensive Care. 2007 Oct;35(5):679-94. doi: 10.1177/0310057X0703500505.
Septic shock is characterised by vasodilation, myocardial depression and impaired microcirculatory blood flow, resulting in redistribution of regional blood flow. Animal and human studies have shown that gastrointestinal mucosal blood flow is impaired in septic shock. This is consistent with abnormalities found in many other microcirculatory vascular beds. Gastrointestinal mucosal microcirculatory perfusion deficits have been associated with gut injury and a decrease in gut barrier function, possibly causing augmentation of systemic inflammation and distant organ dysfunction. A range of techniques have been developed and used to quantify these gastrointestinal perfusion abnormalities. The following techniques have been used to study gastrointestinal perfusion in humans: tonometry, laser Doppler flowmetry, reflectance spectrophotometry, near-infrared spectroscopy, orthogonal polarisation spectral imaging, indocyanine green clearance, hepatic vein catheterisation and measurements of plasma D-lactate. Although these methods share the ability to predict outcome in septic shock patients, it is important to emphasise that the measurement results are not interchangeable. Different techniques measure different elements of gastrointestinal perfusion. Gastric tonometry is currently the most widely used technique because of its non-invasiveness and ease of use. Despite all the recent advances, the usefulness of gastrointestinal perfusion parameters in clinical decision-making is still limited. Treatment strategies specifically aimed at improving gastrointestinal perfuision have failed to actually correct mucosal perfusion abnormalities and hence not shown to improve important clinical endpoints. Current and future treatment strategies for septic shock should be tested for their effects on gastrointestinal perfusion; to further clarify its exact role in patient management, and to prevent therapies detrimental to gastrointestinal perfusion being implemented.
感染性休克的特征是血管扩张、心肌抑制和微循环血流受损,导致局部血流重新分布。动物和人体研究表明,感染性休克时胃肠道黏膜血流受损。这与在许多其他微循环血管床中发现的异常情况一致。胃肠道黏膜微循环灌注不足与肠道损伤和肠道屏障功能下降有关,可能会导致全身炎症加剧和远处器官功能障碍。已经开发并使用了一系列技术来量化这些胃肠道灌注异常。以下技术已用于研究人体胃肠道灌注:张力测定法、激光多普勒血流仪、反射分光光度法、近红外光谱法、正交偏振光谱成像、吲哚菁绿清除率、肝静脉插管以及血浆D-乳酸测量。尽管这些方法都具有预测感染性休克患者预后 的能力,但必须强调的是,测量结果不可互换。不同的技术测量胃肠道灌注的不同要素。由于其非侵入性和易用性,胃张力测定法目前是使用最广泛的技术。尽管最近有了所有这些进展,但胃肠道灌注参数在临床决策中的有用性仍然有限。专门旨在改善胃肠道灌注的治疗策略未能实际纠正黏膜灌注异常,因此未显示能改善重要的临床终点。感染性休克的当前和未来治疗策略应测试其对胃肠道灌注的影响;以进一步阐明其在患者管理中的确切作用,并防止实施对胃肠道灌注有害的治疗方法。